Copyright Reports & Markets. All rights reserved.

Global Steroid APIs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Steroid APIs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Corticosteroids
    • 1.3.3 Progestinics
    • 1.3.4 Anabolics
    • 1.3.5 Estrogens
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Steroid APIs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Industrial
    • 1.4.3 Laboratory
  • 1.5 Global Steroid APIs Market Size & Forecast
    • 1.5.1 Global Steroid APIs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Steroid APIs Sales Quantity (2021-2032)
    • 1.5.3 Global Steroid APIs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Steroid
    • 2.1.1 Steroid Details
    • 2.1.2 Steroid Major Business
    • 2.1.3 Steroid Steroid APIs Product and Services
    • 2.1.4 Steroid Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Steroid Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Steroid APIs Product and Services
    • 2.2.4 Pfizer Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 Bayer
    • 2.3.1 Bayer Details
    • 2.3.2 Bayer Major Business
    • 2.3.3 Bayer Steroid APIs Product and Services
    • 2.3.4 Bayer Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bayer Recent Developments/Updates
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi Steroid APIs Product and Services
    • 2.4.4 Sanofi Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sanofi Recent Developments/Updates
  • 2.5 MSD
    • 2.5.1 MSD Details
    • 2.5.2 MSD Major Business
    • 2.5.3 MSD Steroid APIs Product and Services
    • 2.5.4 MSD Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 MSD Recent Developments/Updates
  • 2.6 Tianjin Tianyao Pharmaceutical
    • 2.6.1 Tianjin Tianyao Pharmaceutical Details
    • 2.6.2 Tianjin Tianyao Pharmaceutical Major Business
    • 2.6.3 Tianjin Tianyao Pharmaceutical Steroid APIs Product and Services
    • 2.6.4 Tianjin Tianyao Pharmaceutical Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Tianjin Tianyao Pharmaceutical Recent Developments/Updates
  • 2.7 Zhejiang Xianju Pharmaceutical
    • 2.7.1 Zhejiang Xianju Pharmaceutical Details
    • 2.7.2 Zhejiang Xianju Pharmaceutical Major Business
    • 2.7.3 Zhejiang Xianju Pharmaceutical Steroid APIs Product and Services
    • 2.7.4 Zhejiang Xianju Pharmaceutical Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
  • 2.8 Tianjin Jinjin Pharmaceutical
    • 2.8.1 Tianjin Jinjin Pharmaceutical Details
    • 2.8.2 Tianjin Jinjin Pharmaceutical Major Business
    • 2.8.3 Tianjin Jinjin Pharmaceutical Steroid APIs Product and Services
    • 2.8.4 Tianjin Jinjin Pharmaceutical Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Tianjin Jinjin Pharmaceutical Recent Developments/Updates
  • 2.9 Henan LIHUA Pharmaceutical
    • 2.9.1 Henan LIHUA Pharmaceutical Details
    • 2.9.2 Henan LIHUA Pharmaceutical Major Business
    • 2.9.3 Henan LIHUA Pharmaceutical Steroid APIs Product and Services
    • 2.9.4 Henan LIHUA Pharmaceutical Steroid APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Henan LIHUA Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Steroid APIs by Manufacturer

  • 3.1 Global Steroid APIs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Steroid APIs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Steroid APIs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Steroid APIs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Steroid APIs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Steroid APIs Manufacturer Market Share in 2025
  • 3.5 Steroid APIs Market: Overall Company Footprint Analysis
    • 3.5.1 Steroid APIs Market: Region Footprint
    • 3.5.2 Steroid APIs Market: Company Product Type Footprint
    • 3.5.3 Steroid APIs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Steroid APIs Market Size by Region
    • 4.1.1 Global Steroid APIs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Steroid APIs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Steroid APIs Average Price by Region (2021-2032)
  • 4.2 North America Steroid APIs Consumption Value (2021-2032)
  • 4.3 Europe Steroid APIs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Steroid APIs Consumption Value (2021-2032)
  • 4.5 South America Steroid APIs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Steroid APIs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Steroid APIs Sales Quantity by Type (2021-2032)
  • 5.2 Global Steroid APIs Consumption Value by Type (2021-2032)
  • 5.3 Global Steroid APIs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Steroid APIs Sales Quantity by Application (2021-2032)
  • 6.2 Global Steroid APIs Consumption Value by Application (2021-2032)
  • 6.3 Global Steroid APIs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Steroid APIs Sales Quantity by Type (2021-2032)
  • 7.2 North America Steroid APIs Sales Quantity by Application (2021-2032)
  • 7.3 North America Steroid APIs Market Size by Country
    • 7.3.1 North America Steroid APIs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Steroid APIs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Steroid APIs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Steroid APIs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Steroid APIs Market Size by Country
    • 8.3.1 Europe Steroid APIs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Steroid APIs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Steroid APIs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Steroid APIs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Steroid APIs Market Size by Region
    • 9.3.1 Asia-Pacific Steroid APIs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Steroid APIs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Steroid APIs Sales Quantity by Type (2021-2032)
  • 10.2 South America Steroid APIs Sales Quantity by Application (2021-2032)
  • 10.3 South America Steroid APIs Market Size by Country
    • 10.3.1 South America Steroid APIs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Steroid APIs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Steroid APIs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Steroid APIs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Steroid APIs Market Size by Country
    • 11.3.1 Middle East & Africa Steroid APIs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Steroid APIs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Steroid APIs Market Drivers
  • 12.2 Steroid APIs Market Restraints
  • 12.3 Steroid APIs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Steroid APIs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Steroid APIs
  • 13.3 Steroid APIs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Steroid APIs Typical Distributors
  • 14.3 Steroid APIs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Steroid APIs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Steroids, also called corticosteroids, are anti-inflammatory medicines used to treat a range of conditions.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Steroid APIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Steroid APIs market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Steroid APIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Steroid APIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Steroid APIs market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Steroid APIs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Steroid APIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Steroid, Pfizer, Bayer, Sanofi, MSD, Tianjin Tianyao Pharmaceutical, Zhejiang Xianju Pharmaceutical, Tianjin Jinjin Pharmaceutical, Henan LIHUA Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Steroid APIs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Corticosteroids
    Progestinics
    Anabolics
    Estrogens
    Others
    Market segment by Application
    Industrial
    Laboratory
    Major players covered
    Steroid
    Pfizer
    Bayer
    Sanofi
    MSD
    Tianjin Tianyao Pharmaceutical
    Zhejiang Xianju Pharmaceutical
    Tianjin Jinjin Pharmaceutical
    Henan LIHUA Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Steroid APIs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Steroid APIs, with price, sales quantity, revenue, and global market share of Steroid APIs from 2021 to 2026.
    Chapter 3, the Steroid APIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Steroid APIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Steroid APIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Steroid APIs.
    Chapter 14 and 15, to describe Steroid APIs sales channel, distributors, customers, research findings and conclusion.

    Buy now